Liver stiffness measurement changes and platelet count have an independent association with cirrhosis or hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease. #GItwitter #gastroenterology

brnw.ch/21wJjTY

Patients with Crohn disease (CD) who were treated with upadacitinib vs placebo had greater clinical and endoscopic improvement regardless of prior biologic exposure. Study in CGH. Laurent Peyrin-Biroulet Remo Panaccione, MD, FRCPC David T. Rubin, MD Dana Lukin MD, PhD #GItwitter

brnw.ch/21wJisx

Maternal vedolizumab levels decrease and ustekinumab levels remain stable throughout pregnancy in patients with inflammatory bowel disease (IBD). Study in CGH. Ralley Prentice Emma Flanagan Emily Wright Jakob Begun Dr Yoon-Kyo An Rimma Goldberg Sally Bell

brnw.ch/21wJhwZ

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is high and growing among patients with type 2 diabetes. Study in CGH. Pegah Golabi James M. Paik #GItwitter #gastroenterology

brnw.ch/21wJgg6

Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations with inflammatory bowel disease (IBD). Study in Gastroenterology. Dr Dermot McGovern Millie Long Nirupama Bonthala MD Gil Y. Melmed, MD, MS Gaurav Syal, MD MHDS Eric Vasiliauskas “DrV” David Ziring

brnw.ch/21wJg18

Fecal immunochemistry testing (FIT)-positive colonoscopy identifies more high-risk findings than symptomatic colonoscopy. Study in Frontiers - Medicine. Lakshman Kumar Elaine joy #GItwitter #gastroenterology

brnw.ch/21wJf7H

Early-onset inflammatory bowel disease (IBD) increases the risk of developing other autoimmune diseases. Mette Wod Bente Mertz Nørgård Center for Clinical Epidemiology #GItwitter #gastroenterology

brnw.ch/21wJeOD

There are shared genetic and environmental risk factors between inflammatory bowel disease (IBD) and spondyloarthritis. Mehdi Osooli Ida Schoultz Tine Jess Scott Montgomery Jonas Halfvarson #GItwitter #gastroenterology

brnw.ch/21wJd5t

Check out our recent publication evaluating the impact of #COVID19 treatment on #IBD outcomes!

Use of pancreatic enzyme therapy is associated w/ a reduction in the incidence rate of acute pancreatitis among children with pancreatic sufficient acute recurrent pancreatitis or chronic pancreatitis. Kenneth Ng, DO Maisam Haija-PANCREAS, MD, MS Amit Grover, MD Dr Keith Chee Y. Ooi
brnw.ch/21wJbvc

A celiac disease (CeD) program improves quality care metrics and resolves symptoms like diarrhea among patients with CeD. Drew Ford, MD 🩺 Kaitlin Payne Kendra Weekley, RD David Gardinier, RD #GItwitter #gastroenterology

brnw.ch/21wJaFb

While inflammatory bowel disease (IBD) treatments are more often withheld in those who develop COVID-19, withholding therapy isn't associated w/ increased IBD flares. Laura C Sahyoun, MD Jonathan Fetene, MD Chandler McMillan Badr Al-Bawardy Jill Gaidos, MD Deborah Proctor
brnw.ch/21wJ8WB

For individuals with class II obesity, endoscopic sleeve gastroplasty is cost saving compared with semaglutide. Study in JAMA Network Open. Muhammad Haseeb Jag Chhatwal Jade Xiao Pichamol Jirapinyo, MD, MPH Chris Thompson, MD #GItwitter #gastroenterology

brnw.ch/21wJ8e0

Breastfeeding is safe and potentially beneficial for mothers with inflammatory bowel disease (IBD) and their offspring. Vivian Huang, MD Parul Tandon #GItwitter #gastroenterology

brnw.ch/21wJ6ia

Low-dose aspirin has a significant association with a decreased risk for gastric adenoma, regardless of a family history of gastric cancer.
CancerTherapyAdvisor #GItwitter #gastroenterology

brnw.ch/21wJ5wc

The adenoma detection rate is higher in artificial intelligence (AI)-assisted and second-observer colonoscopies compared with single-observer colonoscopy. Manesh Kumar Gangwani, MD Rizwan Ishtiaq Fouad Jaber, MD, MS(c) Dushyant Singh Dahiya, MD Hassam Ali, MD Sumant Inamdar Muhammad Aziz

brnw.ch/21wJ40K

Introducing a diet lower in UPFs to participants in remission, and the tracking of disease changes, may help determine how the role of UPF diet contributes to the disease course.Gastroenterology Advisor .AJG - The American Journal of Gastroenterology .

The rate of response to fecal microbiota transplantation administered to the small intestine does not depend on severity of irritable bowel syndrome (IBS). #GItwitter #gastroenterology

brnw.ch/21wJ3mf

Patients with chronic hepatitis B (CHB) treated with entecavir vs tenofovir disoproxil fumarate have no significant long-term differences in all-cause, liver-related, or nonliver-related mortality. Study in Journal of Gastroenterology and Hepatology. Maria Buti Elena Vargas

brnw.ch/21wJ23o

Rezdiffra™ (resmetirom) is now available for use in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).

brnw.ch/21wJ1KR